142 related articles for article (PubMed ID: 75286)
1. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
Tautz C; Schneider W; Laier E; Brügmann G
Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
[No Abstract] [Full Text] [Related]
2. [Experiences with the electrophoretic mobility test in children. A diagnostic help in pediatric oncology? (author's transl)].
Ritter J; Oehme J
Monatsschr Kinderheilkd (1902); 1978 Sep; 126(9):556-60. PubMed ID: 80743
[TBL] [Abstract][Full Text] [Related]
3. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
[TBL] [Abstract][Full Text] [Related]
4. Electrophoretic mobility (EM)-test for childhood cancer diagnosis.
Nitzschke U; Zwergel T; Lampert F
Eur J Pediatr; 1977 Oct; 126(3):163-73. PubMed ID: 71993
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
Lampert F; Nitzschke U; Zwergel T
Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
[TBL] [Abstract][Full Text] [Related]
6. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
Fike RM; van Oss CJ
Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
[TBL] [Abstract][Full Text] [Related]
7. [Evidence that electrophoretic-mobility (EM) test is of no value for the diagnosis of cancer in children (author's transl)].
Lasson U; Scherer G; Müller-Ruchholtz W
Monatsschr Kinderheilkd; 1981 Mar; 129(3):164-7. PubMed ID: 6112683
[TBL] [Abstract][Full Text] [Related]
8. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
9. The electrophoretic mobility test with myelin basic protein, binding of 125I-MBP to lymphocytes, and gel electrophoresis pattern of supernatant during incubation.
Mross K; Mross B; Wolfrum DI; Kohlschütter A
Res Exp Med (Berl); 1980; 177(3):245-53. PubMed ID: 6160602
[TBL] [Abstract][Full Text] [Related]
10. [Aspects of immunologic diagnosis of brain tumors. Results with tumor-associated membrane antigens and the electrophoretic mobility test (author's transl)].
Meyer-Rienecker H; Jenssen HL; Werner H
Arch Psychiatr Nervenkr (1970); 1979; 227(2):121-33. PubMed ID: 543792
[TBL] [Abstract][Full Text] [Related]
11. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
Zhao BH; Hu JK; Liang JX
Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
[No Abstract] [Full Text] [Related]
12. [Immune diagnosis of malignant diseases. X. Value of the electrophoresis mobility test in the diagnosis of broncho-pulmonary diseases].
Douwes FR
Onkologie; 1978 Apr; 1(2):79-84. PubMed ID: 82241
[TBL] [Abstract][Full Text] [Related]
13. The macrophage electrophoretic mobility test for malignancy.
Lubran MM
Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
[No Abstract] [Full Text] [Related]
14. Cellular sensitization in tumor-bearing mice to soluble extracts from normal and malignant tissues. I. Common and individually distinct antigens as detected by electrophoretic mobility (EM) test.
Werner H; Jenssen HL; Köhler H; von Broen B; Pasternak G; Thuy LT; Schlott B; Pasternak L
Eur J Cancer (1965); 1978 May; 14(5):485-90. PubMed ID: 77224
[No Abstract] [Full Text] [Related]
15. Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies.
Douwes FR; Hoffmann W; Mross K
Oncology; 1977; 34(2):80-3. PubMed ID: 70771
[TBL] [Abstract][Full Text] [Related]
16. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W; Werner W; Steiner R; Kaufmann R
Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
[TBL] [Abstract][Full Text] [Related]
17. Effect of lymphocyte supernatants on the electrophoretic mobility of erythrocytes: significance in cancer diagnosis.
Dyson JE; Corbett PJ
Br J Cancer; 1978 Sep; 38(3):401-10. PubMed ID: 708571
[TBL] [Abstract][Full Text] [Related]
18. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
Harlos JP; Weiss L
Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
[TBL] [Abstract][Full Text] [Related]
20. [The electrophoretic-mobility-test (EMT) in the diagnosis of malignancies (author's transl)].
Douwes FR; Hanke R; Mross K
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Dec; 87(3):281-90. PubMed ID: 138274
[No Abstract] [Full Text] [Related]
[Next] [New Search]
